T 2591/18 (Pharmaceutical compsitions comprising nilotinib/NOVARTIS) of 25.01.2022
- European Case Law Identifier
- ECLI:EP:BA:2022:T259118.20220125
- Date of decision
- 25 January 2022
- Case number
- T 2591/18
- Petition for review of
- -
- Application number
- 07820560.6
- IPC class
- A61K 31/506A61P 35/02A61K 9/16
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- PHARMACEUTICAL COMPOSITIONS COMPRISING NILOTINIB OR ITS SALT
- Applicant name
- Novartis AG
- Opponent name
- Generics [UK] Limited
Strawman Limited
Fresenius Kabi Deutschland GmbH
medac Gesellschaft für klinischeSpezialpräparate mbH - Board
- 3.3.07
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 123(2)European Patent Convention Art 56Rules of procedure of the Boards of Appeal 2020 Art 013(2)
- Keywords
- Amendments - allowable (yes)
Admission of arguments on inventive step (Yes)
Main request - Inventive step (Yes) - Catchword
- -
- Cited cases
- T 0247/20
Order
For these reasons it is decided that:
The appeals are dismissed.